Exagen Inc. (XGN)
NASDAQ: XGN
· Real-Time Price · USD
7.52
0.40 (5.62%)
At close: Jun 16, 2025, 3:59 PM
7.79
3.57%
After-hours: Jun 16, 2025, 05:34 PM EDT
5.62% (1D)
| Bid | 7.2 |
| Market Cap | 164.35M |
| Revenue (ttm) | 56.72M |
| Net Income (ttm) | -15.51M |
| EPS (ttm) | -0.85 |
| PE Ratio (ttm) | -8.85 |
| Forward PE | -27.54 |
| Analyst | Strong Buy |
| Ask | 8 |
| Volume | 251,167 |
| Avg. Volume (20D) | 215,392 |
| Open | 7.28 |
| Previous Close | 7.12 |
| Day's Range | 7.28 - 7.72 |
| 52-Week Range | 1.71 - 7.75 |
| Beta | 1.60 |
Analyst Forecast
According to 0 analyst ratings, the average rating for XGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-9.81%
Exagen shares are trading lower after the company ...
Unlock content with
Pro Subscription
10 months ago
+12.65%
Exagen shares are trading higher after the company reported better-than-expected Q2 financial results and increased its FY24 revenue outlook above estimates.
